Get a glimpse into our company and investor data—powered by the PitchBook Platform
Palau Pharma (worldwide rights to lbaconazole development product)
Asset Purch.LATEST DEAL TYPE
Worldwide rights to Palau Pharma's Albaconazole development product. The drug is an oral antifungal agent for the treatment of vulvo-vaginal candidiasis, onychomycosis and other antifungal applications.